(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )
|
|
|
- さや ちゅうか
- 5 years ago
- Views:
Transcription
1
2 (2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( ) / 1 ( ) / 1 ( ) / 3 ( ) / 1 ( ) / 2 ( ) / 3 ( ) / 1 ( ) / 1 ( ) / 1 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 1 ( ) / 1 ( ) / 2 ( ) / 1 ( ) / 1 ( ) / 2 ( ) / 3 ( ) / 4 ( ) / 3 ( ) / 1 ( ) / 3 ( ) / 3 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 1 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 3 ( ) / 3 ( ) / 3 ( ) / 4 ( ) / 4 ( ) / 3 ( ) / 3 ( ) / 1 ( ) / 2 ( ) / 3 ( ) / 1 ( ) / 3 ( ) / 2 ( ) / 3 ( ) / 4 ( ) / 4 ( ) / 4 ( ) / 2 ( ) / 3 ( ) / 3 ( )
3 (2009)... / 3 ( ) / 4 ( ) / 4 ( ) / 2 ( ) / 4 ( ) ()... / 3 ( ) / 3 ( ) / 4 ( ) / 3 ( ) / 4 ( ) / 4 ( ) / 4 ( ) / 4 ( ) I( )... / 1, 2, 3, 4, 5, / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 2 ( ) / 1 ( ), 2 ( ) / 4 ( ) / 5 ( ) / 5 ( )
4 (2009) A-(1) 1 Introduction to Pharmaceutical Sciences 1 1 ( ) 1 ( ) / / 1. 1) 2. 1) QOL 3. 1) ( ) 1. 1 ( ) 2. 2 ( ) 3. 3 ( ) 4. 4 ( ) 5. 5 ( ) 6. 6 ( ) 7. 1 ( ) 8. 1 ( ) 9. 2 ( ) ( ) ( ) ( ) ( ) ( ) 15. ( ) (): (hfukui@ph.tokushima-u.ac.jp) Mail ( B 3, , ncc1701abcde@basic.med.tokushima -u.ac.jp) Mail 4
5 (2009) A-(2),(3) 2 Introduction to Pharmaceutical Sciences 2 1 ( ) 1 ( ) / / / 1. 1) a. b. c. 2) 3) 4) 5) 6) 7) 8) 2. 1) 2) 3) 4) 5) 6) 7)
6 (2009) ( , Mail (, , Mail ( , Mail 6
7 (2009) B(1) 3 Guide to Pharmacy 3 1 ( ) 1 ( ), 2 ( ) ( 2 ) () 1. 1) 1. ( ) 2) 3) 4) 5) 2. 1) 2) 3. 1) 4. 1) 2) 3) 5. 1) 2) ) 2) (, , tsuaraki@ph.tokushima-u.ac.jp) Mail ( 2, , kitoh@ph.tokushima-u.ac.jp) Mail ( : 5 7 ) ( , mochiai@ph.tokushima-u.ac.jp) Mail ( : ) (aotaka@ph.tokushima-u.ac.jp) Mail ( , hkiwada@ph.tokushima-u.ac.jp) Mail ( 6, , ssano@ph.tokushima-u.ac.jp) Mail ( : ) ( 4F, , shishido@ph.toku shima-u.ac.jp) Mail ( , takaishi@ph.tokushima-u.ac.jp) Mail ( , takiguti@ph.tokushima-u.ac.jp) Mail (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 17:30) ( , hchuman@ph.tokushima-u.ac.jp) Mail (, , tsuchiya@ph.tokushima-u.ac.jp) Mail ( : (9:00-16:00)) ( , tokumura@ph.tokushima-u.ac.jp) Mail (hfukui@ph.tokushima-u.ac.jp) Mail
8 (2009) C1(1) 1 Physical Chemistry ) 2) (1 ) 3) 4) 5) ( ) 6) 2. 1) () 2) van der Waals 1 ( ) 1 ( ) / 3) 4) 5) 1. ( ) 2. ( ) 3. Schrodinger (1) ( ) 4. Schrodinger (2) ( ) 5. (1) ( ) 6. (2) ( ) 7. ( ) 8. Pauli ( ) 9. ( ) 10. ( ) 11. ( ) 12. ( ) 13. Huckel ( ) 14. (1) ( ) 15. (2) ( ) () ( 4 ) (E )hchuman@ph.tokushima-u.ac.jp( ) ( : 9:00 12:00 13:00 17:30( )) 8
9 (2009) C1(2), C2(3) 2 Physical Chemistry 2 1 ( ) 1 ( ) / 1. ( ) 1) 2. 1) 2) 3) 4) 5) ( ) 6) 7) 8) 3. 1) 2) 3) 4) 5) 6) 7) 8) ) (Clausius-Clapeyron ) 2) 3) ( ) 5. 1) 2) (1) 5. (2) 6. (1) 7. (2) (1) 11. (2) ( ) (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 12:00 13:00 17:30) htanaka@ph.tokushima-u.ac.jp 2 ( )
10 (2009) C1(3) (4) 3 Physical Chemistry 3 2 (1.0) 1 (0.5) 1. 1) 2) ( ) 2. 1) 2) 3) 4) 5) 6) (Debye-Hückel ) 3. 1) 2) 3) 4) Nernst 5) 4. 1) (1) 3. (2) (1) 7. (2) 8. (1) 9. (2) 10. (1) 11. (2) 12. (1) 13. (2) 14. (1) 15. (2) ( ) 3 ( ) / ( ) (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 12:00 13:00 17:30) htanaka@ph.tokushima-u.ac.jp 3 ( ) 10
11 (2009) C1(3), C2(1) (2) 1 Analytical Chemistry 1 1) ( ) 2) ( ) 3 (0.5)(0.5) (0.5) 1. 1) 2) SI() 3) 4) 2. 1) 2) ph ( ) 3) 4) (Mohr Fajans Volhard ) 5) ( ) 6. 2(pH) ( ) ( ) 1 ( ) / ( ) (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 12:00 13:00 17:30) htanaka@ph.tokushima-u.ac.jp 1 ( ) 11
12 (2009) C1(1), C2(2) (3), C3(1) 2 Analytical Chemistry ) 2. 1) () 2) Lambert - Beer 3) 3. 1) ( ) 2) 3) 4. ( ) 1) 2) 3) ( ) 5. 1) 1 ( ) 2 ( ) / 2) ORD / CD 3) ORD / CD 1. ( ) 2. ( ) 3. (1) ( ) 4. (2) ( ) 5. (3) ( ) 6. (1) ( ) 7. (2) ( ) 8. (3) ( ) 9. ( ) (1) ( ) 10. ( ) (2) ( ) 11. (1) ( ) 12. (2) ( ) 13. (3) ( ) 14. (4) ( ) () () ( 4 ) (E )hchuman@ph.tokushima-u.ac.jp( ) ( : 9:00 12:00 13:00 17:30( )) 12
13 (2009) C2(1) (2) (3) 3 Analytical Chemistry ) 2) 3) 4) 2. 1) 2) 3. 1) 2) 4. 1) 2) 5. 1) 1. 1) 2. 2) 3. 1) 4. 2) 5. 3) 6. 1) 7. 2) ( ) 8. 3) 9. 4) 10. 5) 11. 1) 12. 2) 13. 3) ( ) 3 ( ) / :( 4) ( : 12:00-17:30 E ) 13
14 (2009) C-4-(1) 1 Basic Organic Chemistry C4 (1) (2) (3) (4) () ( ) ( ) 1 ( ) / 15. Fischer Newman () Saytzev Hofmann Markovnikov
15 (2009) ( 4 ) ( 6, , ssano@ph.tokushima-u.ac.jp) Mail ( : ) () ( 6 ) ( ) (E )ssano@ph.tokushima-u.ac.jp 15
16 (2009) C-4-(2) 2 Basic Organic Chemistry II 1 ( ) 1 ( ) / ( ) ( ) Base 1. 1) 2. 1) 2) 3) 4) 1. (1) 2. (2) 3. (3) 4. (4) 5. (1) 6. (2) 7. (1) 8. (2) 9. (1) 10. (2) 11. (3) 12. (4) 13. (1) 14. (2) () 6( ) (E ) aotaka@ph.tokushima-u.ac.jp( ) ) ( :
17 (2009) C-4-(3) 3 Basic Organic Chemistry 3?? ( ) () 3 1 (1.0) 2 (1.0) 1 (1.0) 2 (1.0) () (SN1 SN2 ) 3. (Saytzev ) ( ) 1 ( ) / SN2 ( 6 ) 2. SN2 ( ) 3. SN2 4. SN1 ( 7 ) 5. SN1 / ( ) 6. Hammond 7. SN1 8. ( 9 ) 9. E1 ( 7 ) 10. E1 11. Saytzev 12. E2 ( 7 ) 13. E2 14. () 15. ( 8 ) 16. : I II III ()( 6) (E )mochiai@ph.tokushima-u.ac,jp ) ( : 17
18 (2009) C4-(4) 4 Organic Chemistry 4 1 ( ) 2 ( ) / (NMR) (IR) H-NMR 3. H-NMR 1 4. H-NMR 2 5. C-NMR 6. C-NMR 7. IR 8. UV 9. MASS 10. X 11. CD ( ) 18 () 3F (E )tooi@ph.tokushima-u.ac.jp
19 (2009) C-5-(1) 1 Applied Organic Chemistry 1 1 ( ) 2 ( ) / 1 (1.0) 2 (1.0) 3 (1.0) 2 (0.5) ( ) Claisen 10. β- 11. α- 12. α,β- 13. / ( ) WEB ( , yoshida@ph.tokushima-u.ac.jp) Mail ( : )
20 (2009) C-5-(2) 2 Applied Organic Chemistry ) 2) 2. 1) ) () 5. -3( ) ( ) ( ) ( ) 2 ( ) / ()(4 ) (E )shishido@ph.tokushima-u.ac.jp ( : 12 :00 13 :00) 20
21 (2009) C-6-(1) Bio-organic Chemistry 1 ( ) 2 ( ) /? 1. 1) 2) 3) 4) 2. 1) 3. 1) 2) 1. (1) 2. (2) 3. (1) (2) 5. (3) 6. (1) 7. (2) 8. (3) 9. (4) 10. (1) 11. (2) 12. (3) 13. (1) 14. (2) 15. Chemical Biology () 6 ( ) (E )aotaka@ph.tokushima-u.ac.jp( ) ) ( :
22 (2009) C-6-(2) Medicinal Organic Chemistry ( ) C6 (2) 1. ( ) ( ) 3 ( ) / DNA β : II ( 6, , ssano@ph.tokushima-u.ac.jp) Mail ( : ) () ( 6 ) ( ) (E )ssano@ph.tokushima-u.ac.jp 22
23 (2009) C-7-(1) 1 Natural Medicines 1 1 ( ) 2 ( ) / 1. 1) 2) 2. 1) 2) 3) 3. 1) 2) ) ) 2) (1) 4. (2) (1) / (2) / (3) / ( ) ()( 5 ) (E )kasiwada@ph.tokushima-u.ac.jp 12 :00 13 :00) ( :
24 (2009) C-7(2) 2 Natural Medicines 2 1 ( ) 2 ( ) / / () () 1. 1) 2) 3) 2. 1) 2) 3. 1) 2) 3) (1) 4. (2) (1) / (1) 7. (2) / (2) 8. (3) / (3) 9. (4) / 10. (5) / 11. (6) / 12. (7) / 13. / 14. / 15. / 16. ( ) ()( 5 ) (E )takaishi@ph.tokusima-u.ac.jp kasiwada@ph.tokusima-u.ac.jp ( : 12 :00 13 :00) 24
25 (2009) C-7-(3) 3 Natural Medicines 3 1 ( ) 3 ( ) / ) 2) 3) 4) 5) 6) 7) 2. 1) 2) L III ()( 5 ) (E )takaisi@ph.tokusima-u.ac.jp 12 :00 13 :00) ( :
26 (2009) C8 (2) 1 Biopharmacy ) 2) 2. 1) 2) 3) 3. 1) ( ) 4. 1) 2) 3) 4) 5. 1) 2) ( ) 1 ( ) / ( 5 ) ( , yamazaki@ph.tokushima-u.ac.jp) Mail ( : ) 26
27 (2009) C8-(1) 2 Biopharmacy ) 2. 1) 3. 1) 4. 1) 5. 1) 6. 1) 7. 1) 8. 1) 1 ( ) 1 ( ) / 9. 1),, 1. 1 : ( ), ( ) () (4)TEL: (E )ynakae@dent.tokushima-u.ac.jp ( : 12:00-13:00) 27
28 (2009) C8(4) 3 Biopharmacy 3 ( 2 ) () 1. 1) 2) 2. 1) 2) 3) 4) 5) 6) () 3. 1) 4. 1) 2) 3) 5. 1) 1 ( ) 2 ( ) 1. 1) (30 ) 2) (10 ) 3) (10 )
29 (2009) C-9-(1)(2) 1 Biochemistry 1 1 ( ) 1 ( ) / DNA ( ) ) 2) 2. 1) 2) 3. 1) 4. 1) DNA RNA 2) () 5. 1) 2) DNA RNA 3) 4) 5) ( ) 6) RNA ) DNA RNA 2) 3) RNA 4) RNA 5) 7. 1) DNA 2) ( ) 3) DNA 8. 1) (SNPs) DNA RNA 4. DNA 5. DNA () : : 8,190 ( 7,800 )
30 (2009) 4. ) ( : 30
31 (2009) C9 (3) 2 Biochemistry 2 1 ( ) 1 ( ) / 1. 1) 2) 3) 2. 1) 2) 3) 4) 5) 3. 1) ( ) 2) 3) 4) 5) 4. 1) 2) 1. (Edman ) 2., α β β, 31 3.,, 4. (1) 5. (2) ,, ( ) 9. () 10. (, Km, Vmax, ) 11. ( ) 12. () 13. (, Allosetric Enzyme) ( ) ()3 (E ) yosimura@ph.tokushima-u.ac.jp ) ( :
32 (2009) C-9-(4) 3 Biochemistry 3 1 ( ) 2 ( ) / ) 2. ATP 1) ATP 2) 3) 4) (. 5) β- 6) CoA 7) 8) ATP 9) 10) 3. 1) 2) 3) ( ) 4) 5) 6) 32 7) 8) 9) 4. 1) 2) (1) 6. (2) 7. (3) (1) 10. (2) 11. (3) 12. (1) 13. (2) ( : ) () ( 3 ) (E )tanakat@ph.tokushima-u.ac.jp ) ( :
33 (2009) C9(5) 4 Biochemistry 4 1 ( ) 3 ( ) / 1. 1) 2) 3) 4) 2. 1) 2) 3) ( ) 4) ( ) 5) () 6) 3. 1) 2) 33 3) 4) 4. 1) 2) 3) 5. 1) 2) G 3) 4) ( ) 1., , 5. 6., NO, G - 9. G G - C 11. G TGF 13. Ras-MAPK 14. PI3-Kinase (AKT)
34 (2009) 5 () : ( ) 5 : () ()( 3 ) (E )yosimura@ph.tokushima-u.ac.jp ) ( : 34
35 (2009) C13-(3) Physiology 1 ( ) 4 ( ) / ( ) ( ) ( ) 2. I II 4. I 5. II 6. I 7. II 8. I 9. II 10. I 11. II 12. I 13. II 14. I 15. II ( ) (2,400 + )() (7,600 + ) () (3 ) (E )guchi003@ph.tokushima-u.ac.jp ( : ) 21
36 (2009) C9(2),(6) Gene Technology 1 ( ) 3 ( ) / DNA RNA DNA 1. 1) ( ) 2) 3) 4) ( ) 2. 1) DNA RNA 2) DNA RNA 3) 4) RNA 3. 1) 2) cdna DNA ) RNA 1 ( 5 )H. Lodish, A. Berk, C.A. Kaiser, M.Krieger, M.P. Scott, P. Matsudaira, S. L. Zipursky, J. Darnell, (2005) () () ( 2 ) (E )kitoh@ph.tokushima-u.ac.jp ( : E)
37 (2009) C-10-(1) 1 Cell Biology 1 1 ( ) 1 ( ) / 1. 1) 2) - 3) 4) ( ) 5) 6) 2. 1) 2) 3) 4) 3. 1) 2) MHC 3) T 4) T ( ) 5) () 9. (1) BCR TCR 10. (2) TCR MHC ( ) 4, ( )3, arakaki@ph.tokushima-u.ac.jp ( : )
38 (2009) C10(2) 2 Cell Biology 2 1 ( ) 3 ( ) / (1) 3. (2) yshinoha@genome.tokushima-u.ac.jp 38
39 (2009) C10(3) 3 Cell Biology 3 ( 2 ) () 1. 1) DNA (EB B19 B ) 2) RNA ( A C ) 3) (HIV HTLV) 4) () 5) ( ) 6) ( ) 7) ( ) 1 ( ) 3 ( ) 8) () 9) ( ) 10) 11) ( ) 12) 13) 2. 1) 1. 1) (30 ) 2) (10 ) 3) (10 )
40 (2009) C-11- (2),(3) 1 Pharmaceutical Health Sciences 1 1 ( ) 2 ( ) / / ( ) 1. 1) () 2) 2. 1) 2) 3) 3. 1) 2) (WHO) 4. 1) 2) 5. 1) 2) 40 3) 4) 6. 1) 2). 3) 4) 7. 1) 2) 8. 1) 2) () 3) () 4) 5) () ( )
41 (2009) ( ) ()( 3 ) (E )tokumura@ph.tokushima-u.ac.jp ) ( : 41
42 (2009) C-11- (1) 2 Pharmaceutical Health Sciences 2 1 ( ) 2 ( ) / ( ) ( ) ) 2) 3) 2. 1) 2) (Ames ) 3) 3. 1) 2) PCB 3) 4) (NOAEL) 42 5) (1 ) 6) () 7) () 4. 1) 5. 1) 2) 3) 4) () 5) 6) 7) 8) 9) 6. 1) 2) 3) 4) ( ) (1) 5. (2) (1)
43 (2009) 8. (2) (1) 11. (2) (1) 14. (2) ( ) ()( 3 ) (E )tanakat@ph.tokushima-u.ac.jp ) ( : 43
44 (2009) C-12-(1) (2) Environmental Pharmacy 1 ( ) 3 ( ) / : 1. 1) 2) 3) 4) 5) 6) 2. 1) 2) 3) 4) 5) 6) 7) 3. 1) 2) 44 3) 4) () 4. 1) 2) 3) 4) 5. 1) 2) 3) 6. 1) 2) 3) 4) PRTR 7. 1) 2) 3) 4)
45 (2009) PRTR () ( 3 ) (E )tokumura@ph.tokushima-u.ac.jp ) ( : 45
46 (2009) C13-(1) 1 Basic Clinical Pharmacy 1 1 ( ) 1 ( ) / 1. 1) () 2) ( ) 3) ( ) 4) 5) 6) 7) 2. 1) 2) 3) 4) 5) 6) 7) ) ( ) 2) 3) 4. C13-(1) 1. / 2. / 3. / 4. / 5. / 6. / 7. / 8. / 9. / 10. / / 11. / 12. / 13. / 14. / 15. /
47 (2009) ( 4 ) 1( ) hkiwada@ph.tokushima-u.ac.jp : ) ( 47
48 (2009) C8-(3), C13-(2) 2 Basic Clinical Pharmacy 2 1 ( ) 2 ( ) / ( ) 1. 1) 2. 1) 2) 3) ( ) (2,400 + ) ( ) (7,600 + ) ()( 3 ) (E )hfukui@ph.tokushima-u.ac.jp ( : )
49 (2009) C8-(3), C13-(2), (3) 3 Basic Clinical Pharmacy 3 2 ( ) 1. 1) ( ) 2 ( ) / 5 ( ) (2,400 + ) ( ) (7,600 + ) () (3 ) (E )hfukui@ph.tokushima-u.ac.jp ( : ) 49
50 (2009) C13-(4) 4 Basic Clinical Pharmacy 4 1 ( ) 3 ( ) / 1. 1) 2) 3) ( ) 4) 5) 6) 2. 1) 2) - 3) 4) ( ) 5) () 6) 7) 3. 1) 2) 3) 4) P ) 6) 7) (SNPs ) 8) 9) 4. 1) 2) 3) 4) 5) 6) 7) 5. 1) 2) 1. I ishida@ph.tokushima-u.ac.jp : ) (
51 (2009) C13-(5) 5 Basic Clinical Pharmacy 5 TDM 1 (1.0) 4 (0.5) 1. 1) 2) 3) 1-4) 2-5) 6) 7) 8) 9) 10) 11) 12) 2. TDM (Therapeutic Drug Monitoring) 1) (TDM) 2) TDM 3) 4) 5) 1 ( ) 3 ( ) / 1. (1 ) / 2. AUC (1 ) / (AUC) (1 ) / (1 ) / 1-0 ( ) 5. 1 (1 ) / 1-1 ( ) 6. (2 ) / 1-7. (2 ) / (2 ) / () 9. (2 ) / 10. TDM(2 ) / TDM ( 4 ) 51
52 (2009) : ) ( 52
53 (2009) C14-(1)(2) 1 Pharmacotherapy 1 1 ( ) 3 ( ) / Practical pharmacy 1. 1) 2) 2. 1) 2) 3. 1) 2) 4. 1) 2) ) 2) 1. (1) 2. (2) II ()2 (E )takiguti@ph.tokushima-u.ac.jp ( : )
54 (2009) C-14-(3) 2 Pharmacotherapy 2 aaa 1. 1) ( ) 2) 3) 4) 5) 6) 1 ( ) 3 ( ) / 2. 1) 2) 3) 4) 3. 1) 2) 3) 4. 1) 2) () 3) () 5. 1) 2) 3) 6. 1) 54
55 (2009) 2) 3) 4) 5) 6) 1. () 2. () 3. () 4. () 5. ( ) ( ) 8. ( ) 9. ( 1) 10. ( 2) 11. () 12. ( ) 13. ( ) 14. ( - ) 15. ( ) II (1) ()2 (E )tsuchiya@ph.tokushima-u.ac.jp ( : E ) 55
56 (2009) C14-(4) 3 Pharmacotherapy 3 1 ( ) 4 ( ) / 1. (SBO58,59) 2. ( ) (SBO 60,61) 3. (SBO62, 63) 4. (SBO64) 5. (1) (SBO65, 66)) 6. (2) (SBO67, 68) 7. (1) (SBO69,70) 8. (2) (SBO70-72) 9. (1) (SBO73,74) 10. (2) (SBO75,76) 11. (SBO77,78) 12. (SBO79) 13. (SBO80) (SBO82, 83) 15. (SBO84) 16. 3,, II. (1), () ( )5 (E )tsuaraki@ph.tokushima-u.ac.jp ( : ) 21
57 (2009) C14(5) 4 Pharmacotherapy 4 1 ( ) 4 ( ) / ( , arakaki@ph.tokushima-u.ac.jp) Mail 21
58 (2009) C-15-(1),(2) 1 Drug Informatics 1 () () 1. 1) 2) 3) 2. 1) 2) 3) 4) 3. 1) 4. EBM(Evidence-Based Medicine) 1 ( ) 3 ( ) / 1) EBM EBM 5. 1) (POS) EBM ICT : ( , aiko@ph.tokushima-u.ac.jp) Mail 58
59 (2009) C15-(3) 2 Drug Informatics 2 1 ( ) 3 ( ) / Practical pharmacy 1. 1) 2) 3) 2. 1) 2) 3. 1) 2) ( ) 4. 1) 2) 5. 1) 2) 3) PK/PD (1) 3. PK/PD (2) 4. PK/PD (1) 5. PK/PD (2) 6. PK/PD 7. PK/PD 8. PK/PD 9. PK/PD 10. PK/PD (1) 11. PK/PD (2) 12. TDM (1) 13. TDM 2) 14. TDM III ()2 (E )takiguti@ph.tokushima-u.ac.jp ( : )
60 (2009) C-16-(1),(2) 1 Physical Pharmacy 1 1 ( ) 1 ( ) / 1 2 () 1 (0.5) 2 (0.5) ) 60 2) 3) 4) 2. 1) 2) 3) 4) 5) 3. 1) 2) 3) 4) 5) 6) 7) X 4. 1) 2) 3) 5. 1) 6. 1)
61 (2009) ( ) ( , sueno@ph.tokushima-u.ac.jp) Mail 61
62 (2009) C-1-(4), C-16-(3) 2 Physical Pharmacy 2 1 ( ) 2 ( ) / DDS (Drug Delivery System DDS, ), DDS 1 (0.5) 1 (0.5) DDS DDS 1) 2) DDS 3. 1) ( ) 2) 3) 4) 5) 6) 4. 1) 2) 5. 1) DDS 1) () 9. DDS DDS 15. (DDS) 16. ( ) () ( ) ( ) () ( 5 ) (E )sueno@ph.tokushima-u.ac.jp 12:00-13:00) ( :
63 (2009) B(1), C2(2) Japanese Pharmacopoeia 1 ( ) 3 ( ) / / 1. 1) 2. 1) 2) 3) 4) ( ) 8. ( 1) 9. ( 2) 10. () 11. ( 1) 12. ( 2) 13. ( 1) 14. ( 2) , ( , hkiwada@ph.tokushima-u.ac.jp) Mail ( : 8:30 12:00 13:00 17:30) (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 12:00 13:00 17:30) 63
64 (2009) C-17-(1), (2) 1 Drug Development 1 1 ( ) 1 ( ) / () (3F) (E )tooi@ph.tokushima-u.ac.jp ( : )
65 (2009) C-17-(3), (4) 2 Drug Development 2 1 ( ) 3 ( ) / 1. 1) 2. 1) 3. 1) 1. (1) 2. (2) 3. (1) 4. (2) 5. (1) 6. (2) 7. (1) 8. (2) 9. (3) 10. (4) 11. (5) 12. (6) 13. (7) 14. (1) 15. (2) () 6 ( ) (E )aotaka@ph.tokushima-u.ac.jp( ) ( : )
66 (2009) C-17-(5) 3 Drug Development 3 1 ( ) 2 ( ) / / (CRC) ( GCP ) 1. 1) 2) 3) 4) () ( ) ( ) 5) ( ) 2. 1) ( I II III ) 2) ( ) 3. 1) (t- Mann-Whitney U ) χ2 (Dunnett Tukey ) 2) ( 66
67 (2009) ) () (Kaplan-Meier ) 1. / 2. / 3. / 4. / 5. / 6. / 7. / 8. / 9. / 10. / 11. / 12. / 13. /, 14. / 15. () () ( : E ) ( : E ) 67
68 (2009) C 18-(1),(2) 1 Social Pharmacy 1 1 ( ) 3 ( ) ) 2) 2. 1) 2) 3) 4) 5) 6) 7) 8) 3. 1) 68 2) 3) 4) 4. 1) ( ) 2) OTC 1. ( ) 4,700 ( ) : ( 5671) : E : k takeda@otsuka.jp
69 (2009) C-18-(3) 2 Social Pharmacy 2 ( ), OTC 1. 1) 2) 3) 2. 1) 3. 1) 4. OTC 1) (OTC ) 2) (1) 3. (2) (1) 8. (2) (OTC )(1) 11. (OTC )(2) ( ) 4 ( ) / ( , azuma@ph.tokushima-u.ac.jp) Mail ( : ) 21 69
70 (2009) 1 Advanced Clinical Pharmacy 1 1 ( ) 4 ( ) / / / 1. 1) 2) 3) 4) 2. 1) PK/PD 2) 3) 3. 1) 2) 3) 4) 5) 4. 1) IT 2) 3) 4) PK/PD 6. PK/PD 7. PK/PD 8. PK (, , tsuaraki@ph.tokushima-u.ac.jp) Mail ( , hkiwada@ph.tokushima-u.ac.jp) Mail ( , takiguti@ph.tokushima-u.ac.jp) Mail 21 70
71 (2009) 2 Advanced Clinical Pharmacy 2 1 ( ) 4 ( ) / / / / 1. ( ) 1) 2) 2. ( ) 1) 2) 3) 3. () 1) 2) 4. DDS ( ) 1) DDS 2) DDS 3) DDS DDS 7. DDS 8. DDS ( : ) 2 ( : ) 3 ( : ) 4 ( : ) 21
72 (2009) 1 English for Pharmaceutical Sciences 1 1 ( ) 2 ( ) 1. 1) 2) 2. 1) 2) 3. 1) 2) 1. (, , tsuaraki@ph.tokushima-u.ac.jp) Mail ( 2, , kitoh@ph.tokushima-u.ac.jp) Mail ( : 5 7 ) ( , mochiai@ph.tokushima-u.ac.jp) Mail ( : ) (aotaka@ph.tokushima-u.ac.jp) Mail ( , hkiwada@ph.tokushima-u.ac.jp) Mail ( , sano@basic.med.tokushima-u.ac.jp) Mail ( 4F, , shishido@ph.toku shima-u.ac.jp) Mail 72 ( , takaishi@ph.tokushima-u.ac.jp) Mail ( , takiguti@ph.tokushima-u.ac.jp) Mail (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 17:30) ( , hchuman@ph.tokushima-u.ac.jp) Mail (, , tsuchiya@ph.tokushima-u.ac.jp) Mail ( : (9:00-16:00)) ( , tokumura@ph.tokushima-u.ac.jp) Mail (hfukui@ph.tokushima-u.ac.jp) Mail
73 (2009) 2 English for Pharmaceutical Sciences ) 2) 2. 1) 2) 3. 1) 2) (, , tsuaraki@ph.tokushima-u.ac.jp) Mail ( 2, , kitoh@ph.tokushima-u.ac.jp) Mail ( : 5 7 ) ( , mochiai@ph.tokushima-u.ac.jp) Mail ( : ) (aotaka@ph.tokushima-u.ac.jp) Mail ( , hkiwada@ph.tokushima-u.ac.jp) Mail ( 6, , ssano@ph.tokushima-u.ac.jp) Mail ( : ) 1 ( ) 3 ( ) ( 4F, , shishido@ph.toku shima-u.ac.jp) Mail ( , takaishi@ph.tokushima-u.ac.jp) Mail ( , takiguti@ph.tokushima-u.ac.jp) Mail (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 17:30) ( , hchuman@ph.tokushima-u.ac.jp) Mail (, , tsuchiya@ph.tokushima-u.ac.jp) Mail ( : (9:00-16:00)) ( , tokumura@ph.tokushima-u.ac.jp) Mail (hfukui@ph.tokushima-u.ac.jp) Mail 73
74 (2009) Pathology 1 ( ) 3 ( ) / () () 7. ( ) 8. () 9. ( ) 10. ( ) 11. ( ) 12. () 13. ( ) ( ) 14. ( ) 15. () ( 4 ) ( , izumi@basic.med.tokushima-u.ac.jp) Mail ( : ) 74
75 (2009) Pathology () 1. 1) 2) 3) 4) 5) 2. 1) 2) 3) 4) 5) 6) 7) 8) 1. 1 ( ) 3 ( ) / ; ( ) () ()() ()1 (E )sano@basic.med.tokushima-u.ac.jp ) ( : 75
76 (2009) Integrative Medicine 1 ( ) 4 ( ) / / OTC OTC OTC ()5 (E )takaisi@ph.tokushima-u.ac.jp kasiwada@ph.tokushim a-u.ac.jp ( : ) 21 76
77 (2009) Neuroscience 1 ( ) 4 ( ) / ) 2) 3) 4) 2. 1) () 2) 3) 4) 5) 6) 3. 1) 2) 3) 4) 4. 1) 2) ) 2) / , 13. (1) 14. (2) 15. (3) () ( 3 ) (E )yosimura@ph.tokushima-u.ac.jp ) 21 ( :
78 (2009) C3(2) Structural Biology 1 ( ) 2 ( ) / 1. ( ) yshinoha@genome.tokushima-u.ac.jp 78
79 (2009) Drug Safety Study 1. : 2. : 3. : 4. : 5. : ( ) 4 ( ) / : & ( - D ) 1 4( ) () () () 272 ( ) ( ) ( , aiko@ph.tokushima-u.ac.jp) Mail 21 79
80 (2009) C1(1) (2) (4) C3(2) C4(1) (2) C6(1) (2) () Pharmacoinformatics 1 ( ) 3 ( ) / - () ) 2) 3) 4) 2. 1) ( ) 2) 3. 1) Hammett 2) 3) 4. 1) (1) 3. - (2) (1) 6. (2) 7. (3) 8. (1) 9. (2) ( ) 10. (1) 11. (2) 12. (3) 13. (4) ( ) 14. (5) ( )() ( 4 ) (E )hchuman@ph.tokushima-u.ac.jp( ) ( : 9:00 12:00 13:00 17:30)
81 (2009) C-4-(1) Inorganic Chemistry 1 ( ) 3 ( ) / 1 (0.5) ( ) 1. 1) 2) 3) 4) 2. 1) 2) 3) 4) 3. 1) 2) 3) 4) 5) 6) 7) ) 2) 3) 4) 5) 5. 1) 2) 3) 4) 5) () 6) 7)
82 (2009) ( ) ( ) () ( 5 ) (E )sueno@ph.tokushima-u.ac.jp 12:00-13:00) ( : 82
83 (2009) C18-(2) Pharmacoeconomics 1 ( ) 4 ( ) / 1 EBM(Evidence-Based Medicine) 1. 1) 2. 1) 2) 3) 3. 1) 2) 4. 1) 2) 5. 1) 2) 6. EBM (Evidence-Based Medicine) 1) EBM 83 2) QOL QOL : ( ) () (E )kawazoe@clin.med.tokushima-u.ac.jp ( : 9 17 ) 21
84 (2009) C-6-(2) 1 Medicinal Chemistry 1 1 ( ) 3 ( ) / ( ) ( ) () ( ) 1 (1.0) 2 (1.0) 3 (1.0) 2 (1.0)(1.0) 1 (1.0) ( ) / 2. / 1 3. / 2 4. / 3 5. / 6. HMG-CoA / 1 7. HMG-CoA / 2 8. H2 / 1 9. H2 / ( ) / ( ) / / 13. / 14. / / : :; ( , mochiai@ph.tokushima-u.ac.jp) Mail ( : )
85 (2009) Clinical Psychology 1 ( ) 4 ( ) /(0.5) / (0.5) /(0.5) () (E )youko@ias.tokushima-u.ac.jp ( : ) 21
86 (2009) 1 Internal Medicine 1 1 ( ) 4 ( ) / / / / / / / 1. 1) 2) 3) 4) 5) 2. 1) 2) 3) 4) 3. 1) 2) 3) 4) 5) 1. ( ) 2. ( ) 3. ( ) 4. ( ) ( ) 6. ( ) 7. ( ) 8. ( ) 9. ( ) 10. () 11. () 12. () 13. ( ) 14. ( ) 15. ( ) :/ : :NIM 4 : 2 / 21
87 (2009) 2 Internal Medicine 2 C-7(2) 1 ( ) 4 ( ) / / / / / / / / / 1. 1) ( ) 2) ( ) 3) 4) 5) ( ) 6) 2. 1) 2) 3) 4) 5) : 3 / 2 : 21
88 (2009) C-7(2) 3 Internal Medicine 3 1 ( ) 4 ( ) / / / / 1. 1) 2) 3) 4) 2. 1) 2) 3. 1) 2) 4. 1) 2) : ( ) 2 / 21
89 (2009) C2(2) C3(1) Practice in Physical Chemistry 1 ( ) 2 ( ) / / 1(1 ) 2(2 ) ( ) ( ) 1 (1.0) 2 (1.0) 3 (0.5) ( ) 1. 1) ph 2. 1) 3. 1) 2) 4. 1) 5. 1) () 3. () 4. ( 1) 5. ( 2) 6. ( 1) 7. ( 2) ( , takeuchi@ph.tokushima-u.ac.jp) Mail ( : 9:00 12:00 13:00 17:30) (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 9:00 12:00 13:00 17:30) 89
90 (2009) C-1-(1), C-2-(1), (2), (3), C-3-(1), C-16-(1) - 1 Practice of Physical Chemistry 1 1) :: 1 (0.5)(1.0) 1 (0.5) 2 (0.5) (ph) 3. ph ( ) 2 ( ) / ( ) ( ) ( ) ( , sueno@ph.tokushima-u.ac.jp) Mail 90
91 (2009) B2(4), C1(1), C3(1), C18(1), (2) 2 Practice in Physical Chemistry 2 1 ( ) 2 ( ) / / 1(1 ) 2 ( 2 ) ( ) ( ) ) 2) 2. 1) 2) 3. 1) 2) 3) 4) ) ( ) 3. () 4. ( 1) 5. ( 2) 6. ( - ) 7. ( -) 8. () ( 4 ) (E )hchuman@ph.tokushima-u.ac.jp( ) ( : 9:00 12:00 13:00 17:30)
92 (2009) C4(3)(4) 1 Organic Chemistry Laboratory (1 3) H NMR 4. IR 5. 1 ( ) 2 ( ) / : ( ) : ( ) ( 6, , ssano@ph.tokushima-u.ac.jp) Mail ( : ) () ( 6 ) ( ) (E )ssano@ph.tokushima-u.ac.jp 92
93 (2009) C-5-(1), (2) C-4-(4) 2 Organic Chemistry Laboratory 2 1 ( ) 2 ( ) / / / 2 1 1H NMR 1. / 2. / 3. / 4. / 5. / NMR : :( ) ( ) 93
94 (2009) C6-(2) 3 Organic Chemistry Laboratory 3 1 ( ) 2 ( ) / / / ( ) p- 2. (Aldol ) 3. Indole (Fischer ) 4. (Cannizzaro ) : : ( ) :( ) : - - ( ) aotaka@ph.tokushima-u.ac.jp( ) nem@ph.tokushima-u.ac.jp( ) tooi@ph.tokushima-u.ac.jp( ) 94
95 (2009) C-9-(3) 1 Practice of Biochemistry ) 2) 2. 1) 2) 3) 4) 5) 6) 3. 1) 2) 3) ( ) 2 ( ) / : ( ) ()3 (E )yosimura@ph.tokushima-u.ac.jp ) ( : 95
96 (2009) C-9-(6) C-10-(2) 2 Practice of Biochemistry 2 1 ( ) 2 ( ) / / / / DNA (cloning) ) DNA 2) DNA ) PCR ) 2) ELISA / 1 DNA / 2 DNA / 3 DNA DNA / 4 DNA PCR / 5 () ( 2F) (E )kitoh@ph.tokushima-u.ac.jp( ) yshinoha@gen ome.tokushima-u.ac.jp( ) yamazaki@ph.tokushima-u.ac.jp( ) dtsuji@ph.tokushima-u.ac.jp ( ) ( : E) 96
97 (2009) C8-(4) 3 Practice of Biochemistry 3 1 ( ) 2 ( ) / / 1. 1) 2) 2. 1) 2) 3) 4) 1. ( 3) :1 (1998) Y=6,300 2 Brock (2003)Michael T. Madigan Y=18,900 3 ( 2 )(2003) Y=2,415 4 Molecular Cell Biology (5th ed.) Lodish (1999) Y=8, ()4 ( : )
98 (2009) C-13-(1,2) 4 Practice of Biochemistry 4 1 ( ) 2 ( ) / / / 4() ()( 3 ) (E )hfukui@ph.tokushima-u.ac.jp guchi003@ph.tokushima -u.ac.jp horio@ph.tokushima-u.ac.jp ( : ) 98
99 (2009) C7-(1)(2) Pharmacognosy Experiment 1 ( ) 2 ( ) / / ) ( ) 2) ( ) 3) ( ) 4) ( ) 2. 1) ( ) 2) ( ) 3) ( ) 3. 1) ( ) 2) ( ) 3) ( ) 4) ( ) ) ( ) 2) ( ) 1. () ()( 5 ) (E )kasiwada@ph.tokushima-u.ac.jp 12:00-13:00) ( :
100 (2009) C13-(1), C13-(4), C13-(5), C16-(3) Practice of Biopharmaceutics 1 ( ) 3 ( ) / / 1 : ph (in situ ) 2: ( ) (in vivo ) 3: P-450 (in vitro ) 4: 7 (in silico ) 1. ( ) 2. ( ) 3. ( ) ( ) ( ) 6. ( ) 7. ( ) 8. ( ) 9. ( ) 10. ( ) 11. ( ) hkiwada@ph.tokushima-u.ac.jp : ) ( 100
101 (2009) C-11-(1) C-12-(2) Practice of Health Chemistry 1 ( ) 2 ( ) / / 1. 1) 2) 2. 1) 2) DO, BOD, COD 3. 1) 1. / () / ( ) / () / (DPD ) 2. / DO ( ) / BOD () / COD ( ) 3. / () / () / 4. / () / ( ) / () 5. / ( / TLC ) () 2005 ( ) 1 2 ( ) () ( 3 F ) (E )tokumura@ph.tokushima-u.ac.jp tanakat@ph.to kushima-u.ac.jp ( : ) 101
102 (2009) B-(2) Pharmacy Experience 1 ( ) 1 ( ), 2 ( ) 1. 1) 2. 1) 3. 1) 4. 1) 5. 1) AED () ( , takiguti@ph.tokushima-u.ac.jp) Mail (hfukui@ph.tokushima-u.ac.jp) Mail
103 (2009) (I) Pharmacy Practice Pretraining 4 ( ) 4 ( ) 1. 1) 2) 3) 4) 5) ( ) 6) 7) 8) 9) ( ) 10) 11) 2. 1) 103 2) 3) 4) 5) 6) 7) () 8) 9) 10) 11) () 12) () 13) ( ) 14) ( ) 15) 16) 17) 18) ( ) 19) ( ) 20) ( ) 21) ( ) 22) ( ) 3. 1) 2) 3) 4) 5) ( ) 6)
104 (2009) 7) 8) ( ) 9) 10) 11) 12) 13) () 4. 1) 2) 3) 4) 5) 6) 7) ( ) 8) 9) 10) 11) ( ) 12) ( ) 13) 14) ( ) 15) 16) 17) 18) ( ) 19) () 20) ( ) 21) 22) 23) ( ) 24) 25) ( ) 26) 27) 28) 5. 1) 2) 3) 4) 5) 6) 7) 8) 9) 10) ( ) 11) ( ) 6. 1) QOL 2) 3) 4) 5) 6) ( ) 7) () 8) ( ) 9) 10) 11) 12) ( ) ( ) 13) 14) 15) () 104
105 (2009) 16) () 17) ( ) 18) ( ) 7. 1) 1. () (E ) :azuma@ph.tokushima-u.a c.jp ( : E )
106 (2009) (II) Pharmacy Practice Hospital Pharmacy 1. 1) 2) 3) 4) 5) 6) 7) ( ) 8) 9) 10) () 11) () 10 ( ) 5 ( ) 12) 13) 14) 15) 16) ( ) 17) ( ) 18) 19) ( ) 20) 21) 22) 23) ( ) 24) () () 25) ( ) 26) () ( ) 27) 28) ( ) ( ) 29) ( ) 30) ( ) 31) 32) () 33) 34) 35) 36) () 106
107 (2009) 37) 38) 39) () ( ) 40) ( ) 41) ( ) 42) () ( ) 43) 44) ( ) 45) 46) ( ) ( ) 47) ( ) 48) 49) 50) 51) 52) ( ) 53) ( ) 54) ( ) 55) () ( ) 2. 1) 2) 3) 4) 5) 6) 7) 8) 9) 10) ( ) 11) 12) ( ) 13) ( ) 14) ( ) 15) ( ) ( ) 16) 17) 18) 3. 1) (DI) 2) 3) 4) 5) 6) 7) 8) MR( ) ( ) 9) DI ( ) 10) ( ) 11) 12) ( ) 13) () 14) ( 107
108 (2009) ) 15) ( ) 4. 1) 2) 3) ( ) 4) 5) ( ) 6) 7) ( ) 8) () 9) 10) ( ) 11) (5W1H) ( ) ( ) 12) ( ) 13) ( ) 14) 15) 16) () 17) ( ) 18) () 19) () 20) () 21) () 22) () 23) ( ) 24) SOAP ( ) 25) () 26) () 27) 28) ( ) 29) ( ) 5. 1) 2) 3) ( () )( ) 4) ()( ) 5) 6) TDM () 7) 8) () 6. 1) 2) ( ) 3) ( ) 4) ( ) 5) ( ) 6) ( ) 7) ( ) 108
109 (2009) 1. ( ) () (E ) :azuma@ph.tokushima-u.a c.jp ( : E )
110 (2009) (III) Pharmacy Practice Community Pharmacy 10 ( ) 5 ( ) 1. 1) ( ) 2) 3) 4) 5) 6) 7) 8) 9) 10) 11) ( ) 12) () ) 14) 15) 16) ( ) ( ) 2. 1) 2) 3) ( ) 4) ( ) 5) 6) ( ) () 7) ( ) ( ) 8) ( ) 9) ( ) 10) 11) ( ) 12) ( ) 13) 14) () 15) () 16) ( )
111 (2009) 3. 1) 2) 3) 4) 5) 6) () 7) ( ) 8) 9) 10) () 11) ( ) 12) () 13) ( ) ( ) 14) 15) ( ) 16) () 17) () 18) () 19) () 20) 21) 22) ( ) 23) ( ) 19) 24) 25) 26) 27) 28) 29) ( ) 30) () 31) () ( ) 32) ( ) 33) ( ) 34) () ( ) 35) ( ) 36) ( ) ( ) 37) 38) ( ) 39) 40) () 41) 42) () 43) 44) 45) ( ) 46) 47) 48) ( ) 49) ( ) 50) ( ) 51) ( ) 52) 53) ( ) 54) ( ) ( ) 55) () 111
112 (2009) 56) () 57) () 58) 59) 60) 61) 62) 63) 64) 65) ( ) ( ) 66) 67) 68) () 69) 70) ( ) 71) 72) ( ) 73) ( ) 74) 4. 1) 2) 3) ( ) 4) ( ) 5) () 6) () 7) 8) ( ) 9) 10) 11) () 12) () 13) () 14) () 5. 1) 2) 3) 4) 5) ( ) 6) 7) 8) 9) () 10) 11) 12) 13) 14) 15) 16) 17) 18) () 19) 20) 6. 1) 112
113 (2009) 2) 3) 4) ( ) 5) QOL ( ) 1. ( ) () (E ) :azuma@ph.tokushima-u.a c.jp ( : E )
114 (2009) E2 I( ) 1 ( ) 1, 2, 3, 4, 5, 6 / / 1 2 ( ) 1. 1 ( ):90 1 (): 1 ( 8 ) (, , tsuchiya@ph.tokushima-u.ac.jp) Mail ( : E ) 114 ( , azuma@ph.tokushima-u.ac.jp) Mail
115 (2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( ) / 1 ( ) / 1 ( ) / 3 ( ) / 1 ( ) / 2 ( ) / 3 ( ) / 1 ( ) / 1 ( ) / 1 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 1 ( ) / 1 ( ) / 2 ( ) / 1 ( ) / 1 ( ) / 2 ( ) / 3 ( ) / 3 ( ) / 1 ( ) / 3 ( ) / 3 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 1 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 3 ( ) / 3 ( ) / 3 ( ) / 4 ( ) / 4 ( ) / 3 ( ) / 1 ( ) / 2 ( ) / 3 ( ) / 1 ( ) / 3 ( ) / 2 ( ) / 3 ( ) / 2 ( ) / 3 ( ) / 2 ( ) ()... / 3 ( ) / 3 ( ) / 3 ( ) / 3 ( ) / 3 ( )
116 (2009) 2... / 3 ( ) / 4 ( ) / 4 ( ) / 4 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / / / / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 2 ( ) / 3 ( ) / 2 ( ) / 1 ( ), 2 ( )
117 (2009) A-(1) 1 Introduction to Pharmaceutical Sciences 1 1 ( ) 1 ( ) / / 1. 1) 2. 1) QOL 3. 1) ( ) 1. 1 ( ) 2. 2 ( ) 3. 3 ( ) 4. 4 ( ) 5. 5 ( ) 6. 6 ( ) 7. 1 ( ) 8. 1 ( ) 9. 2 ( ) ( ) ( ) ( ) ( ) ( ) 15. ( ) (): (hfukui@ph.tokushima-u.ac.jp) Mail ( B 3, , ncc1701abcde@basic.med.tokushima -u.ac.jp) Mail 117
118 (2009) A-(2),(3) 2 Introduction to Pharmaceutical Sciences 2 1 ( ) 1 ( ) / / / 1. 1) a. b. c. 2) 3) 4) 5) 6) 7) 8) 2. 1) 2) 3) 4) 5) 6) 7)
119 (2009) ( , Mail (, , Mail ( , Mail 119
120 (2009) B(1) 3 Guide to Pharmacy 3 1 ( ) 1 ( ), 2 ( ) ( 2 ) () 1. 1) 1. ( ) 2) 3) 4) 5) 2. 1) 2) 3. 1) 4. 1) 2) 3) 5. 1) 2) ) 2) (, , tsuaraki@ph.tokushima-u.ac.jp) Mail ( 2, , kitoh@ph.tokushima-u.ac.jp) Mail ( : 5 7 ) ( , mochiai@ph.tokushima-u.ac.jp) Mail ( : ) (aotaka@ph.tokushima-u.ac.jp) Mail ( , hkiwada@ph.tokushima-u.ac.jp) Mail ( 6, , ssano@ph.tokushima-u.ac.jp) Mail ( : ) ( 4F, , shishido@ph.toku shima-u.ac.jp) Mail ( , takaishi@ph.tokushima-u.ac.jp) Mail ( , takiguti@ph.tokushima-u.ac.jp) Mail (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 17:30) ( , hchuman@ph.tokushima-u.ac.jp) Mail (, , tsuchiya@ph.tokushima-u.ac.jp) Mail ( : (9:00-16:00)) ( , tokumura@ph.tokushima-u.ac.jp) Mail (hfukui@ph.tokushima-u.ac.jp) Mail
121 (2009) C1(1) 1 Physical Chemistry ) 2) (1 ) 3) 4) 5) ( ) 6) 2. 1) () 2) van der Waals 1 ( ) 1 ( ) / 3) 4) 5) 1. ( ) 2. ( ) 3. Schrodinger (1) ( ) 4. Schrodinger (2) ( ) 5. (1) ( ) 6. (2) ( ) 7. ( ) 8. Pauli ( ) 9. ( ) 10. ( ) 11. ( ) 12. ( ) 13. Huckel ( ) 14. (1) ( ) 15. (2) ( ) () ( 4 ) (E )hchuman@ph.tokushima-u.ac.jp( ) ( : 9:00 12:00 13:00 17:30( )) 121
122 (2009) C1(2), C2(3) 2 Physical Chemistry 2 1 ( ) 1 ( ) / 1. ( ) 1) 2. 1) 2) 3) 4) 5) ( ) 6) 7) 8) 3. 1) 2) 3) 4) 5) 6) 7) 8) ) (Clausius-Clapeyron ) 2) 3) ( ) 5. 1) 2) (1) 5. (2) 6. (1) 7. (2) (1) 11. (2) ( ) (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 12:00 13:00 17:30) htanaka@ph.tokushima-u.ac.jp 2 ( )
123 (2009) C1(3) (4) 3 Physical Chemistry 3 2 (1.0) 1 (0.5) 1. 1) 2) ( ) 2. 1) 2) 3) 4) 5) 6) (Debye-Hückel ) 3. 1) 2) 3) 4) Nernst 5) 4. 1) (1) 3. (2) (1) 7. (2) 8. (1) 9. (2) 10. (1) 11. (2) 12. (1) 13. (2) 14. (1) 15. (2) ( ) 3 ( ) / ( ) (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 12:00 13:00 17:30) htanaka@ph.tokushima-u.ac.jp 3 ( ) 123
124 (2009) C1(3), C2(1) (2) 1 Analytical Chemistry 1 1) ( ) 2) ( ) 3 (0.5)(0.5) (0.5) 1. 1) 2) SI() 3) 4) 2. 1) 2) ph ( ) 3) 4) (Mohr Fajans Volhard ) 5) ( ) 6. 2(pH) ( ) ( ) 1 ( ) / ( ) (, , htanaka@ph.tokushima-u.ac.jp) Mail ( : 8:30 12:00 13:00 17:30) htanaka@ph.tokushima-u.ac.jp 1 ( ) 124
125 (2009) C1(1), C2(2) (3), C3(1) 2 Analytical Chemistry ) 2. 1) () 2) Lambert - Beer 3) 3. 1) ( ) 2) 3) 4. ( ) 1) 2) 3) ( ) 5. 1) 1 ( ) 2 ( ) / 2) ORD / CD 3) ORD / CD 1. ( ) 2. ( ) 3. (1) ( ) 4. (2) ( ) 5. (3) ( ) 6. (1) ( ) 7. (2) ( ) 8. (3) ( ) 9. ( ) (1) ( ) 10. ( ) (2) ( ) 11. (1) ( ) 12. (2) ( ) 13. (3) ( ) 14. (4) ( ) () () ( 4 ) (E )hchuman@ph.tokushima-u.ac.jp( ) ( : 9:00 12:00 13:00 17:30( )) 125
126 (2009) C2(1) (2) (3) 3 Analytical Chemistry ) 2) 3) 4) 2. 1) 2) 3. 1) 2) 4. 1) 2) 5. 1) 1. 1) 2. 2) 3. 1) 4. 2) 5. 3) 6. 1) 7. 2) ( ) 8. 3) 9. 4) 10. 5) 11. 1) 12. 2) 13. 3) ( ) 3 ( ) / :( 4) ( : 12:00-17:30 E ) 126
127 (2009) C-4-(1) 1 Basic Organic Chemistry C4 (1) (2) (3) (4) () ( ) ( ) 1 ( ) / 15. Fischer Newman () Saytzev Hofmann Markovnikov
128 (2009) ( 4 ) ( 6, , ssano@ph.tokushima-u.ac.jp) Mail ( : ) () ( 6 ) ( ) (E )ssano@ph.tokushima-u.ac.jp 128
129 (2009) C-4-(2) 2 Basic Organic Chemistry II 1 ( ) 1 ( ) / ( ) ( ) Base 1. 1) 2. 1) 2) 3) 4) 1. (1) 2. (2) 3. (3) 4. (4) 5. (1) 6. (2) 7. (1) 8. (2) 9. (1) 10. (2) 11. (3) 12. (4) 13. (1) 14. (2) () 6( ) (E ) aotaka@ph.tokushima-u.ac.jp( ) ) ( :
130 (2009) C-4-(3) 3 Basic Organic Chemistry 3?? ( ) () 3 1 (1.0) 2 (1.0) 1 (1.0) 2 (1.0) () (SN1 SN2 ) 3. (Saytzev ) ( ) 1 ( ) / SN2 ( 6 ) 2. SN2 ( ) 3. SN2 4. SN1 ( 7 ) 5. SN1 / ( ) 6. Hammond 7. SN1 8. ( 9 ) 9. E1 ( 7 ) 10. E1 11. Saytzev 12. E2 ( 7 ) 13. E2 14. () 15. ( 8 ) 16. : I II III ()( 6) (E )mochiai@ph.tokushima-u.ac,jp ) ( : 130
131 (2009) C4-(4) 4 Organic Chemistry 4 1 ( ) 2 ( ) / (NMR) (IR) H-NMR 3. H-NMR 1 4. H-NMR 2 5. C-NMR 6. C-NMR 7. IR 8. UV 9. MASS 10. X 11. CD ( ) () 3F (E )tooi@ph.tokushima-u.ac.jp
132 (2009) C-5-(1) 1 Applied Organic Chemistry 1 1 ( ) 2 ( ) / 1 (1.0) 2 (1.0) 3 (1.0) 2 (0.5) ( ) Claisen 10. β- 11. α- 12. α,β- 13. / ( ) WEB ( , yoshida@ph.tokushima-u.ac.jp) Mail ( : )
133 (2009) C-5-(2) 2 Applied Organic Chemistry ) 2) 2. 1) ) () 5. -3( ) ( ) ( ) ( ) 2 ( ) / ()(4 ) (E )shishido@ph.tokushima-u.ac.jp ( : 12 :00 13 :00) 133
134 (2009) C-6-(1) Bio-organic Chemistry 1 ( ) 2 ( ) /? 1. 1) 2) 3) 4) 2. 1) 3. 1) 2) 1. (1) 2. (2) 3. (1) (2) 5. (3) 6. (1) 7. (2) 8. (3) 9. (4) 10. (1) 11. (2) 12. (3) 13. (1) 14. (2) 15. Chemical Biology () 6 ( ) (E )aotaka@ph.tokushima-u.ac.jp( ) ) ( :
< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
2009年度 東京薬科大学 薬学部 授業計画
2009 2 234 Tokyo University of Pharmacy and Life Sciences since 880 Tokyo University of Pharmacy and Life Sciences Department of Clinical Pharmacy Men's Division Department of Clinical Applied Pharmacy
2 English III Lecture Ready 1 Exploring Content 2 English IV Lecture Ready 1 Exploring Content 2 Microbiology II Chemistry of Biomolecules II Enzymology Biochemistry of Metabolism Physiology Plant Physiology
総合薬学講座 生物統計の基礎
2013 10 22 ( ) 2013 10 22 1 / 40 p.682 1. 2. 3 2 t Mann Whitney U ). 4 χ 2. 5. 6 Dunnett Tukey. 7. 8 Kaplan Meier.. U. ( ) 2013 10 22 2 / 40 1 93 ( 20 ) 230. a t b c χ 2 d 1.0 +1.0 e, b ( ) e ( ) ( ) 2013
...a.T.X 04_PDF.p
2004 Sustainable Focus DAAM P19 P32 P42 P19 P41 P18 P16-17 P22 P23 4 21 KYOWA BIO-INNOVATOR 1. 2. 3. 4. 5. 6. 7. 8. 9. Kyowa Hakko Group s Sustainability Universe OUT CO2 SOx NOx IN OUT 2 MR IN OUT CONTENTS
東京薬科大学_120305.indd
履 修 要 項 1 教 育 制 度 2 教 育 課 程 3 単 位 基 準 4 卒 必 要 単 位 数 5 卒 認 定 総 合 科 専 門 科 学 科 別 専 門 科 合 必 修 科 選 択 科 合 年 次 別 学 科 別 授 科 単 位 配 分 表 必 修 科 区 分 授 科 学 年 次 単 位 数 年 年 年 年 年 年 区 分 授 科 学 年 次 単 位 数 年 年 年 年 年 年 必 修 科
橡NO005-PDF用.ec5
(Biotechnology, Cell Biology, Genetics, Immunology, Medicine, Neuroscience, Structural Biology) (Cancer, Genetics, Immunology, Molecular Cell Biology, Neuroscience) InfoPort TEL: 043-290-2262 FAX:
04菊池氏.indd
KIKUCHI Sakae 1 1 1899 32 2000 1966 1.58 1990 1.57 2000.15 2 32 13 2 3 4 18 39.6 25 216,974 106,594 110,380 12 22 5 4.72 12 6 25 33 60 90 25 35 23 24 3 25 7 25 35 45 2 2002.9 4 1925 2003 1997 8 1975 25
JR東日本会社要覧2012-2013
Technology Planning Department Frontier Service Development Laboratory Advanced Railway System Development Center Safety Research Laboratory Disaster Prevention Research Laboratory Technical Center Environmental
98-02.PDF
1 982 2207 CAS 67630 2- H 3 C H 3 C CH OH C 3 H 8 O 60.10 1 99.9 % n- 1. 2-88.5 3 82.5 3 11.7c.c. 455 4 212 d 20 4 0.78505 3 2.1 = 1 4 4.4 kpa 33 mmhg20 4 log Pow0.05 0.07 5 m/z45, 1.0 43 0.19 27 0.17
Principles of Agricultural Sciences MOT Advanced Applied Biological Sciences Advanced Bioenvironmental Conservation Advanced Crop Production Advanced Life and Food Science Advanced Agricultural Economics
CD納品用.indd
1. 1.1 1.2 1.3 1.4 2. 3. 3.1 3.2 3.3 4. 4.1 4.2 6. Journal of the Institute of Nuclear Safety System Journal of the Institute of Nuclear Safety System Journal of the Institute of Nuclear Safety System
Special IssueDiagnoses and therapeutic agents for age-related diseases Reviews Original Case reports β Medicinal drugs affecting on clinical laboratory blood test results and adverse effects of them
No.2
Views and Actions MR MR OPIR OPIR Office of Pharmaceutical Industry Research Points of Views GCP GCP GCP GCP CRC CRC CRC CRC CRC IRB CRC CRC CRC patientoriented patientoriented IT CRC patient oriented
History I COE
2008 108-8641 5-9-1 TEL 03-5791-6334FAX 03-5791-6335 e-mailgakufu@lisci.kitasato-u.ac.jp 228-8555 1-15-1 TEL 042-778-9760FAX 042-778-9761 e-mailnyushi@kitasato-u.ac.jp URL http://www.kitasato-u.ac.jp/lisci/index.html
1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915
Microsoft Word - web.docx
12 10 E 16:30 17:30 : ( ) " " ( ) 12 10 15:50 16:20 A 1 ( ) ( ) B ( ) ( ) D ( ) ( 12 11 B 10:00 12:00 " " ( ) ( ) 2 (10 ) A 1 ( ) 8:30 12:40 8:30 9:20 1 ( ) 1A-01 Cannabidiol-2',6'-dimethyl ether ( 1,
訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書
1... 1 2... 3 I... 3 II... 3 1.... 3 2....15 3....17 4....19 5....25 6....34 7....38 8....48 9....58 III...70 3...73 I...73 1....73 2....82 II...98 4...99 1....99 2....104 3....106 4....108 5.... 110 6....
untitled
CONTENTS 01 02-03 04-05 06-07 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 48-49 50-51 52 01 02 Mishima,Michiaki 03 04 05 06 07 09 10 11
Microsoft Word - プログラム（タイトル）.docx
8:55-9:00 9:00-10:15 O1 O5 9:00 O1 1 1 2 1 1 2 9:15 O2 HDAC 1 1 1 1 2 3 9:30 O3 1 1 1 1 2 3 9:45 O4 inos/nox 1)2) 1) 1) 1. 2. 10:00 O5 GAD67-GFP knockin CRH GABA 1,2 2 3 4 2 1 2 3 4 10:15-10:25 10:25-11:25
Microsoft Word - Ｈ22年度雄勝中央病院卒後臨床研修プログラム.docx
3 2 380 32 1 202,812 11,967 17.2 1,441 129 24 1 6 1 3 1 2 3 50-60 /2 2 2 1-2 2 1 2 2 1 1-2 1 CPC / 4 / / 2 / AED ICLS JPTEC 3 a: b: c: d: 4 c,d a b d 70% 2 10 4 11 12 21 7 21 8 5 Evidence Based Medicine
“÷Œò›ï48
48 37 773 1 18 100 214 1 50 2 5 7 OSCE (Objective Structured Clinical Examination) 8 10 14 15 16 6 19 20 21 21 22 22 25 26 26 27 27 20 28 2 1 Over the counter 50 80 30 502 3 60 404 3 OTC OTCOver the counter
- 2 -
- 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -
2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1
1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4
20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472
I? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................
1 (1) (2)
1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)
-1-
-1- -2 - 2000 1 1 5-3 - 21 10 2-4 - 5-5 - -6 - -7- -8 - 21 2000 21-9- IT in silico 10-10 - -11 - 20 21 1993 ICH - 12 - 2007 4 1 NIHThe National Institutes of Health2004 NIH NIH 2006 UK Clinical Research
09＿理学部案内S2.indd
Okayama University Faculty of Science Okayama University Faculty of Science 2009 1 2 4 6 10 14 18 22 26 27 28 29 30 32 34 36 37 CONTENTS Okayama University Faculty of Science 1 Okayama University Faculty
untitled
2009518 9:109:20 A 9:2010:20 O-01 9:209:30 RNAODN CREST O-02 9:309:40 CREST O-03 9:409:50 NO O-04 9:5010:00 -- O-05 10:0010:10 闐闐 ERATO O-06 10:1010:20 DNA B 10:2011:20 O-07 10:2010:30 O-08 10:3010:40
専攻科シラバス 一般科目
(Practical English) () 12 2 2 TOEIC TEST TOEIC 1. TOEIC TEST 2. B () 2 Unit 1 Shopping 2 Unit 2 Entertaiment Weather 2 Unit 3 Eating out 2 Unit 4 Travel 2 Unit 5 Health 2 2 Unit 6 Housing Media 2 Unit
(1) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (5) (6) (7) (1) (1) (2) (3) (1) (2) (3) (4) (1) (2) (3) (4) (5) (1) (2) (3)
(1) (2) (3) (1) Word (2) 1 (3) Excel (4) Excel (5) 2 (6) Power Point (7) 3 (8) HP HP HP (9) 1 HP (10) Excel (11) 2 (12) Excel (13) 3 (1) (2) (1) (1) (2) (3) (4) (1) (2) (3) (4) (1) (2) (3) (4) (5) (6)
第６１巻５・６号（１２月号）／特集１頁目（本刷）
Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture
再生医科学研究所年報 Annual Report of the Institute for Frontier Medical Sciences Kyoto University Institute for Frontier Medical Sciences 1 2 3 4 5 6 Institute for Frontier Medical Sciences 1 Annual Report 2011
履 歴 書
,,,,,, Carboplatin and Monthly Paclitaxel Carboplatin and Weekly Paclitaxel 8(1), 25-34 (2006) Masayoshi KOINUMA, Takahisa YAMANASHI, Miwako KAMEI, Makoto SHIRAGAMI, The realities and Medical Expense of
県立大学薬学研究科2016四校.indd
1 Naoto Oku, Ph.D. Dean, Graduate Division of Pharmaceutical Sciences 2 3 Graduate Division of Pharmaceutical Sciences, University of Shizuoka Graduate Program in Pharmacy Pharmacy Practice & Science Graduate
< F83582E C0B2D929>
Welfare Society Public Involvement 231 General Theory of Social Welfare Statistics 232 Ethics Ethics 233 Modern Society and Public Quality General Theory of Law 234 General Theory of Law (Include International
H16 2-4_Shirabasu
H HMGCoA Flore Pharmacia! PHS A B C D E JR NHK Statistics AB EG CD F GIO TEL E-mail okochi@ps.toyaku.ac.jp English GIO Nature TEL E-mail ohnom@ps.toyaku.ac.jp TEL E-mail morimoto@ps.toyaku.ac.jp
北辰同窓会37号
37 AUG, 2011 37 4 3,500 291 4040 40 6 4 1 40 OB 1020 23 5 29 11 00 14 00 OSAKA 6 2-5-25 1 2 340 4 1 6 30 5 23 313 67 3 5 27 5 50 3 50 6 25 2 11 10 4 340 40 1 5 30 40 12 8 2011 4 23 7 9 16 00 17 00 7 23
30 (Electrical Engineering I) () LED IC 1. LED, IC D () 2 2 LED 6 4 ANDORNOTEXOR : : () () () () () 1 LED, IC 2 LED, IC LED, I
30 (Information Processing I) () 2 1 2 Word Excel WordExcel 1. EXCEL,WORD 2. D () 2 10 4 2 10 2 30 : () () () () () 1 EXCEL,WORD EXCEL,WORD EXCEL,WORD EXCEL,WORD 2 30 (Electrical Engineering I) () 2 1
免疫Ⅱ
100 100 100 1990 127 DNA DNA DNA DNA hybridization DNA RNA DNA DNA 128 12 µδγαε 129 300 1,200 500 50012 4 24,000 1,20024,000 2.910 7 10 8 rejection major histocompatibility complex MHC MHC MHC 130 MHC
C 1) 2) 3) 4) 5) 6) 7) 8) 9)
130603 (1-3) C 1) 2) 3) 4) 5) 6) 7) 8) 9) C 1) 2) 3) DNA 4) DNA RNA 5) 6) PCR 7) DNA C Cyclops Odlilon Redon, The Cyclops, 1914 WAGR www.wagr.org WAGR www.wagr.org Cell 126, 663-676, 2006 Wikipedia
Vol. 36, Special Issue, S 3 S 18 (2015) PK Phase I Introduction to Pharmacokinetic Analysis Focus on Phase I Study 1 2 Kazuro Ikawa 1 and Jun Tanaka 2
Vol. 36, Special Issue, S 3 S 18 (2015) PK Phase I Introduction to Pharmacokinetic Analysis Focus on Phase I Study 1 2 Kazuro Ikawa 1 and Jun Tanaka 2 1 2 1 Department of Clinical Pharmacotherapy, Hiroshima
1937 100 Q&A Q A 6 6 Q&A Q A EBM Q &A Q A 1 100 1 0 Q A WHO 1978 6000 1 2 17. 106 109, 2005., 1998 Q&A Q A C 1986 2 Narrative Based Medicine NBM NBM Q A Q: A 38 AT MD DO DO 1890 DD 2002 2007 3 2007
GDP GDP 1 98% 2
2016 2016 4 6 [ ] 1 1.1 1.1.1 1. 2. 3. 2 1 4. 1 700-800 1 GDP GDP 1 98% 2 1.1.2 BOD Biochemical Oxygen Demand BOD COD Chemical Oxygen Demand COD DO DO PM2.5 eg.1 GDP CO 2 eg.2 Life Cycle Assessment 3 eg.
88 1A AB 1.????,. () 200 A 100,,,.. (,, )..,,,,,,,,,,, [], [ ], [ ],,, [ ],, [ ], [],.. 7
![88 1A AB 1.????,. () 200 A 100,,,.. (,, )..,,,,,,,,,,, [], [ ], [ ],,, [ ],, [ ], [],.. 7](/thumbs/91/104739061.jpg "88 1A AB 1.????,. () 200 A 100,,,.. (,, )..,,,,,,,,,,, [], [ ], [ ],,, [ ],, [ ], [],.. 7")
87 --I 1A09021 1.0 1 2 AB 1-35,,,, () 20 -- 300 A 100 1 2 3,,,,,, 1 4 16 - furukubo-tokunaga.gm@u.tsukuba.ac.jp [] 2 4 23 - [] 3 5 7 kinaba@shimoda.tsukuba.ac.jp 4 5 14 sasakura@kurofune.shimoda.tsukuba.ac.jp
GCP 1) CSDDTufts Center for the Study of Drug Development 1980 2) 1980 6 1990 GCP 1997 GCP 198090 GCP 1990 2002 35 2000 3) 1) No.7 2002 2) Tufts Center for the Study of Drug DevelopmentOUTLOOK 20012002
,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = /
1 9625 2219 CAS 75569 1, 2-1, 2- H 2 C CH CH 3 C 3 H 6 O 58.08 1 99 % 1. 2 2, 3-112.13 2, 3 34.23-37 449 2.8-37 % 2 d 0 4 0.859 4 d 20 0.8304 2 2, 4 2.00 = 1 53.33 kpa 400 mmhg18 59.33 kpa 445 mmhg20 5
第84回日本遺伝学会-抄録集.indd
A S1 9 24 14 00 17 00 Epigenomic regulation of cell fate determination and homeostasis Organizers: (National Institute of GeneticsKyushu University 14 00 S1-1 1 RIKEN BioResource Center 2 Graduate School
研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
30 II (Japanese II) ( ) ( ) B ( ) I III : ( ) : ( ) : ( ) ( ) ( ) ( ) ( ) ( )
II (Japanese II) () () 2 2 2 1. 2. 3. 4. B () 6 8 8 6 6 10 6 10 60 60 30 10 I III : (): (): () () () () () () 1 2 3 4 II (Geography History II) () () 2 2 2 1. 2. 3. 4. C () 1. 2 10 12 10 10 10 1989 1991
2(2) / (1) (1) -2
1(1) -1 2(2) / (1) (1) -2 3(2) (2) (3) (4) (5) -3 4(1) 1 1-4 5(2) 2-1 -5 6(1) (1) (1) (2) (2) -6 7(2) (1) -7 8-8 9-9 10-10 11 (1) -11 12(1) -12 13(2) -13 14(3) -14 15-15 BOD CH4 COD DO EIA GDP GRP JICA
01-全体表紙.PDF
1 2005 11 26 1 1 5 15 18 1 1. 2005 11 26 09 00 1245 12 45 18207 2. 1,000 2,000 3. 4,000 2,000 5,000 4. 10,000 2,000 30,000 5. 1 20 10 1300 17 00 1500 1700 6. 7. TEL 047-372-4111 821 FAX 047-373-9901 E-MailAPI-jimu@cuc.ac.jp
橡99-24_00 アリルアルコール.PDF
1 9924 2260 CAS 107186 H 2 C CH CH 2 OH 2- -1- C 3 H 6 O 58.08 1 99 1. 2, 3 3, 4, 5-129 96-97 2 21c.c. 24o.c. 2 6, 7 378 6, 7 2.5-18 d 20 4 0.8540 2, 5 2.00 = 1 2.7 kpa 20 mmhg204.3 kpa 32 mmhg30 4 log
精神障害者
13 ACT 156-8585 2-1-8 TEL03-3304-5701 14 10 30 ACTassertive community treatment 1 ACT ACT ACT ACT Fidelity ScaleACT ACT ACT ACT ACT Fidelity 2000, 2001; 1994 Tessler & Gamache 2000 14 1 2002 1986 1994
CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa
1 200117 21512 CAS 111693 110 NC(CH 2 ) 4 CN 1,4- C 6 H 8 N 2 108.14 1 99 2-1. 2 1 295 159 c.c. 550 3 1.7-4.9 20 d 0.965 4 3.73 = 1 0.3 Pa 0.002 mmhg20 2 log Pow-0.32 m/z 41, 1.0 68 0.54 54 0.43 4 Koc9-16
CEO 2017.10.30 Agenda Agenda ) 2000 2000 10 ~ ~ GLP: Good Laboratory Practice GCP: Good Clinical Practice GMP: Good Manufacturing Practice GPSP: Good Post-marketing Study 1 10,000 Practice GLP GMP GCP
NL16-1_0329
No.16-1 March. 2012 JAMTTC News Letter http://jamttc.umin.jp/ Japanese Association for Molecular Target Therapy of Cancer 135-85503-8-31 TEL: 03-3520-0111 ext.5413 FAX: 03-3570-0484 ...1 JAMTTC2012...2...3...4...5
04-p45-67cs5.indd
Journal of Sport and Exercise Psychology Motivation in sport and exercise. Journal of Sport and Exercise Psychology Journal of Applied Sport Psychology Psychological Review International Journal of Behavioral
16,,, 38, (1990) 17 J Toxicol Sci, 15 (Suppl IV), (1990) 18 Cognitive enhancers ( ), 13, (1990) ,, 120, (1991) 20,
1974 1,, 25, 1385-1391 (1974) 1983 2,, 34, 1451-1454 (1983) 1984 3,, Phencyclidine (PCP),, 4, 133-147 (1984) 1985 4,,,, 11, 132-146 (1985) 1986 5 Phencyclidine Angel Dust, 138, 178-180 (1986) 6, 6, 660-666
untitled
BCP 1 23 4 1 p.1 1.1 p.1 1.2 p.1 1.3 p.2 1.4 p.3 1.5 p.5 1.6 p.5 1.6.1 1.6.2 1.6.3 2 p.8 2.1 p.8 2.2 p.9 2.3 p.9 2.4 p.9 2.4.1 2.4.2 2.4.3 2.5 p.11 2.5.1 2.5.2 2.6 p.12 2.6.1 2.6.2 3 p.15 3.1 p.15 3.2
_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf
A. B. C. D. E. GIO SBO, MR Medical representative CRO contract research organization,,, HIV MR MR MR MR MR CRO contract research organization CRA CRO CRA I IV, CBT OSCE CBT computer based testing OSCE
化学4月P001通常総会資料+t三
I 9. 0 9 0 AV 0 7 7 0 7 0 7 0 0 0 0 7 9 9 0 59 5 55 5 7 5 9. 9 7 9 9. 0 0 JST 9. 9 9 0 NMR 5 DNA 57 in vivo 5 ArF DME D 5 IT NMR 5. Robert West. 7 9 00 . 9 9 7 7 5 9 0 000 000 : 9 0 5 9 0 0 7 HP : 9 9
3 É I 1949 Loevinger Jurimetrics 1) ) computer law legal informatics Black's law dictionary 3) 4) Web ç1 legal research legal information system
3 É I 1949 Loevinger Jurimetrics 1) 1976 2) computer law legal informatics Black's law dictionary 3) 4) Web ç1 legal research legal information systems = ç2 computer law legal informatics = 5) É 1970 1998
第１章 製薬産業を取り巻く環境変化
2015 2007 5 1 2 2015 2007 5 103-0023 3-4-1 5F TEL : 03-5200-2681 FAX : 03-5200-2684 E-mail : sasabayashi-opir@jpma.or.jp URL : http://www.jpma.or.jp/opir/ 3 4 5 6 1 2 3 4 1 2 3 4 5 6 7 8 9 10 11 2013 2014
環境報告書2015.indd
ENVIRONMENTAL and SOCIAL REPORT 2015 1 C O N T E N T S 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 1 2 4 5 6 7 8 14 18 20 22 24 25 28 29 2 1 37.1 62.9 2 3 1 4 2 5 6 3 1 4 1 2 7 8 8 5 1 9 2 10 10 2 11 2
4 15:10-15:50 ips 13 15:50-16:15 in vitro 14 16:15-16: :40-17: :05-17: :30-17:55 10, (), ( ), () *1A02 (),,, *1A03 FRET (), (),
(*Outstanding Poster Presentation ) 1F 12 14 1 10:30-10:55 2 10:55-11:20 3 11:20-11:45 1 11:45-12:25 MEMS 2 15:10-15:50 UT-Heart 4 15:50-16:15 5 16:15-16:40 6 16:40-17:05 7 17:05-17:30 RNA ips 8 17:30-17:55
11 10:50-11: :15-11:40 R 3 11:40-12:20, 4 15:10-15:50 ips 13 15:50-16:15 in vitro 14 16:15-16: :40-17: :05-17: :30-17:55
(*Outstanding Poster Presentation ) 1F 12 14, 1 10:30-10:55 2 10:55-11:20 3 11:20-11:45 5 16:15-16:40 6 16:40-17:05 7 17:05-17:30 RNA ips 8 17:30-17:55 1 11:45-12:25 MEMS, 2 15:10-15:50 UT-Heart 4 15:50-16:15
H28.4 / 11 28 7 1 28 28 1 27 29 30 4 1 29 5 5 2 2 1 2 2 28 3 1 28 http://www.city.saitama.jp/005/001/018/003/p036471.html 2 28 7 11 28 8 31 3 CD DVD 4 4 5 7 11 8 31 9 1 9 30 10 1 10 31 11 1 11
08医療情報学22_1_水流final.PDF
22 (1), 702002: 59 59- The Problem of Nursing Common Language for the Information Sharing in Clinical Practice The fact-finding in regard to the correspondence between name and content of nursing action
2014 6 7 12 原 著 S 1, 2 1 1 1 1 2 1 2 2012 6 1 2013 8 26 S S S 148 4 72 49 6 / 60 7 / 12 20 7 / S S OTC 7
2014 6 1 6 Review Article Proposal for Outcome Verification of Iyakubungyo and Future Directions Miwako Kamei 1, Mitsuko Onda 2, Kazuko Akagi 3, Tomohide Akase 4, Noriko Fukushima 5, Noriko Miyamoto 6
KYOWA 07_eco_PDF.p
27 27 13 7 38 19 35 9 11 43 27 P4 276NPO 3BIOKYOWA P4 BIOKYOWA 2761 26 2626427 32626112 27 http://www.kyowa.co.jp/csr/sustain/index.html.....................................................................................
27 ... 1... 1... 2... 4... 4... 5... 11... 11... 11... 11... 15... 15... 17... 19 X A... 21... 23... 25 B... 27... 29... 31... 33... 35... 37... 39... 41... 43... 45... 47... 48 UA NCCU... 48... 50...
NL10
Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
ッ ー ー ー() () 2.5 () () 21 1) -1 2) -2 10 m 5 7 23 6 1)2) 3) -1-2 H23.4.25 -15-20 4 75 5 1) -1 (5) (3) (3) (2) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) 1) ( 23 6 8 ) 2) 22 3)
PREFACE This report contains data on degrees awarded at Jackson State University by academic discipline, educational level and gender for the years. A
FIFTEEN REPORT OF DEGREES CONFERRED BY ACADEMIC DISCIPLINES PREFACE This report contains data on degrees awarded at Jackson State University by academic discipline, educational level and gender for the
